120 related articles for article (PubMed ID: 6804590)
1. Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide.
Hamilton JA; Zabriskie JB; Lachman LB; Chen YS
J Exp Med; 1982 Jun; 155(6):1702-18. PubMed ID: 6804590
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.
Hamilton JA; Slywka J
J Immunol; 1981 Mar; 126(3):851-5. PubMed ID: 6161965
[TBL] [Abstract][Full Text] [Related]
3. Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium.
Andrews HJ; Cawston TE; Hazleman BL
Biochim Biophys Acta; 1990 Jan; 1051(1):84-93. PubMed ID: 2297544
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 stimulation of synovial cell plasminogen activator production.
Mochan E; Uhl J; Newton R
J Rheumatol; 1986 Feb; 13(1):15-9. PubMed ID: 3486284
[TBL] [Abstract][Full Text] [Related]
6. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
Hamilton JH; Bootes A; Phillips PE; Slywka J
Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
Mizuno K; Okamoto H; Horio T
J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activity of rheumatoid and nonrheumatoid synovial fibroblasts.
Hamilton JA
J Rheumatol; 1982; 9(6):834-42. PubMed ID: 6891721
[TBL] [Abstract][Full Text] [Related]
9. Synovial cell activation. Studies on the mechanism of action of synovial activator activity.
Hamilton JA
J Rheumatol; 1983 Dec; 10(6):872-80. PubMed ID: 6420560
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.
Ogawa T; Kotani S; Fukuda K; Tsukamoto Y; Mori M; Kusumoto S; Shiba T
Infect Immun; 1982 Dec; 38(3):817-24. PubMed ID: 7152675
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator and prostaglandin E2 levels in human synovial fibroblasts. Differential stimulation by synovial activator and other cytokines.
Leizer T; Hamilton JA
J Immunol; 1989 Aug; 143(3):971-8. PubMed ID: 2787354
[TBL] [Abstract][Full Text] [Related]
12. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
Tandon P; Utsugi T; Sone S
Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
[TBL] [Abstract][Full Text] [Related]
13. Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.
Zídek Z; Maśek K; Jiricka Z
Infect Immun; 1982 Feb; 35(2):674-9. PubMed ID: 6976939
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus.
Hamilton JA
J Rheumatol; 1983 Dec; 10(6):845-51. PubMed ID: 6686611
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of tumour necrosis factor production and sensitivity to interleukin-2 of human peripheral blood mononuclear cells stimulated by lipopolysaccharide and muramyl dipeptide in vitro.
Rakhmilevich AL; Shneiderova MA; Korobko VG; Chuvpilo SA
Biomed Sci; 1990; 1(5):517-23. PubMed ID: 2133069
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.
Lafyatis R; Thompson NL; Remmers EF; Flanders KC; Roche NS; Kim SJ; Case JP; Sporn MB; Roberts AB; Wilder RL
J Immunol; 1989 Aug; 143(4):1142-8. PubMed ID: 2663990
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
Leclerc C; Chedid L
Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue activating peptide III. Induction of synthesis and secretion of plasminogen activator by synovial fibroblasts.
Ragsdale CG; Castor CW; Roberts DJ; Swartz KH
Arthritis Rheum; 1984 Jun; 27(6):663-7. PubMed ID: 6539601
[TBL] [Abstract][Full Text] [Related]
20. Induction of membrane-associated interleukin 1 alpha (IL-1 alpha) by synergistic activation of human blood monocytes with interferon gamma and muramyl dipeptide analog.
Okubo A; Sone S; Tanaka M; Fukuta K; Inamura N; Nakanishi M; Maeda K; Yanagawa H; Nishioka Y; Yamashita C
Tokushima J Exp Med; 1989 Dec; 36(3-4):97-105. PubMed ID: 2484023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
